Antitubercular agents
Nationwide Coverage of Molecular Drug Susceptibility Testing in South Korea Reveals Room for Improvement
Research conducted at Sungkyunkwan University School of Medicine in Suwon, South Korea, has shed light on the coverage of molecular drug susceptibility testing (mDST) among patients with pulmonary multidrug/resistant tuberculosis (MDR/RR-TB) in the country. The study, which analyzed data from 2015 to 2021, found that while mDST coverage